Cancer Vaccines
Vaccinations
Vaccines
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma Virus (RSV) and Cancer
Ethical Dilemmas I
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 22, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
A F Nicol1, C V Andrade2, F B Russomano2
1Laboratório Interdisciplinar de Pesquisas Médicas, Fiocruz, Instituto Oswaldo Cruz, Rio de Janeiro, RJ, Brasil.
Human papillomavirus (HPV) vaccines offer a positive risk-benefit profile with minimal adverse effects, similar to other vaccines. Independent monitoring is recommended to ensure unbiased safety assessments for HPV vaccination programs.
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: